Emergence of treatment-resistant infectious HIV after genome-directed antiviral endonuclease therapy

• K.R. Jerome,
• D. Stone,
• H.S. De Silva Feelixge,
• P. Roychoudhury,
• J.T. Schiffer

Affiliations

K.R. Jerome

Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA; Department of Laboratory Medicine, University of Washington, Seattle, WA, USA; Department of Microbiology, University of Washington, Seattle, WA, USA

D. Stone

Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA

H.S. De Silva Feelixge

Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA

P. Roychoudhury

Department of Biochemistry, University of Washington, Seattle, WA, USA

J.T. Schiffer

Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA; Department of Medicine, University of Washington, Seattle, WA, USA